Last updated on August 2019

Phase 3, Multicenter, A Phase 3 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Withdrawal Study Evaluating ADV7103 In Pediatric And Adult Subjects With Distal Renal Tubular Acidosis (dRTA)


Brief description of study

This is a phase 3, prospective, multicenter, randomized, double-blinded, placebo-controlled, study product withdrawal study comparing the efficacy of ADV7103 versus placebo in preventing the development of metabolic acidosis defined by serum bicarbonate level in pediatric (6 months to < 18 years of age) and adult (18 to 65 years of age) subjects with primary dRTA

 

Clinical Study Identifier: TX227898

Find a site near you

Start Over